Top Tweets for #CAS12
Wortgefechte aus Stahl und Silben
✨💥📚🛠️🧠
„Biologische Kampfstoffe sind das Gegenteil von Flugabwehrraketen: weniger Metall, mehr Mikrobiologie – und definitiv nichts, was man mit einem Schraubenschlüssel entschärft.“
#Bundeswehr #Wehrpflicht #Deutschland #Cas12 #CRISPR
📣 Final Call for Papers — Cas12-mediated Genome Editing in Plants
Submit research, reviews & tech advances on Cas12 variants, delivery systems, gene analysis & big data for crop improvement.
🗓️ Deadline: Nov 30, 2025
https://t.co/mm3jhXAIL5
#Cas12 #PlantBiotech
🧬 New insights into the diversity of #CRISPR–Cas systems!
#Metagenomic analyses uncovered 4,112 Cas12 proteins and 6 novel subtypes with distinct features.
💻 #AI-based Cas12fam annotates 18 domains.
🔬 Conserved glycines in RuvC-I/II are crucial for dsDNA cleavage.
🌿 #Cas12 subtypes show habitat-specific enrichment.
🔗https://t.co/Tk1jF0NRib #microbiome #Bioinformatics
Going beyond #CRISPR/Cas9, this special issue focuses on #Cas12 for #GenomeEditing in #PlantScience. Plenty of time to get your papers edited and checked for accidental image re-use (and other issues) by our #ImageIntegrity team! https://t.co/0y3kEOw5h3
🧬 ✂️ 🌱 Call for papers for our upcoming special issue on #Cas12 mediated #GenomeEditing in #plantscience! Submission deadline November 30, 2025. @wileyplantsci (Thanks to our publisher, Wiley, for the spiffy graphic)
Learn more here: https://t.co/UztaHbpy4K
🧬 ✂️ 🌱 Call for papers for our upcoming special issue on #Cas12 mediated #GenomeEditing in #plantscience! Submission deadline November 30, 2025. @wileyplantsci (Thanks to our publisher, Wiley, for the spiffy graphic)
Learn more here: https://t.co/UztaHbpy4K
🎉We are thrilled to announce a #CallForPapers for a #JIPB special issue on Cas12-mediated #GenomeEditing in #plants! Details here➡️ https://t.co/QR47EwOgIq
Meanwhile, check out this study⬇️co-authored by Lanqin Xia, one of our special issue guest editors! https://t.co/9DDKe2mP68
We published research detailing the characterization of 12 novel #Cas12 effectors in the @CRISPRjournal, expanding the known diversity of Type V #CRISPR systems and unlocking promising candidates for the development of new #geneediting tools.
Read more: https://t.co/kvNq6Qsv8s
🚀🔬🧬
اكتشاف قد يغير قواعد التعديل الجيني!
الجميع تقريباً يعرف إنزيمات #Cas9 و #Cas12 الي تُستخدم في تقنية #CRISPR والي تشترك في نسبة off-target عالية نسبياً لكن الآن يظهر لاعب جديد على الساحة اسمه #Cas5 بآلية قطع فريدة ودقيقة🧬✨
على عكس Cas9 الي يقطع السلسلتين معًا، وCas12 الي يقطع السلسلة المستهدفة ثم السلسلة الثانية تلقائياً ولكن الجديد ان (Cas5-HNH) يقطع السلسلة المستهدفة أولًا بدقة عالية قبل السلسلة الثانية، مما يجعله أكثر أمانًا وأقل عرضة للأخطاء!
هذا الاكتشاف سيقود بإذن الله إلى تقنيات تعديل جيني أكثر كفاءة وأقل مخاطر، مما يمهد الطريق لعلاجات جينية أكثر دقة!
@BeamTx 12/@BeamTx is IMO the #CRISPR company with the most extensive & vast collaboration agreements portfolio: 1)@VerveTx - sold to @EliLillyandCo 2) $SANA - non-exclusive license for #Cas12 3)@PrimeMedicine-exclusive rights for #PrimeEditing for transition mutations. $APLS $PFE $PRME
⚠️📝Happy to share the recent work from @alessan_porch @NedaBagheri @AndreaIdili in @angew_chem ! #Cas12 #CRISPR #biosensors #stranddisplacement
👉https://t.co/MTOsUbzXF5
Genome editing in rice mediated by miniature size Cas nuclease SpCas12f
#CRISPR #Cas12
@ryukoku_univ_pr @FrontGenEditing
https://t.co/GRwtw9Ri6o
13/@BeamTx is IMO the #CRISPR company with the most extensive & vast collaboration agreements portfolio: 1)@VerveTx - cardiovascular disease 2) $SANA - non-exclusive license for #Cas12 3)@PrimeMedicine-exclusive rights for #PrimeEditing for transition mutations. $APLS $PFE $PRME
CRISPR-Cas12a:
Functional overview and applications
https://t.co/sCbqwKbwRU #OpenAccess #Cas12 #CRISPR
8/@BeamTx is also, as of today, the #CRISPR company with the most extensive & vast collaboration agreements portfolio: 1)@VerveTx - cardiovascular disease 2) $SANA - non-exclusive license for #Cas12 3)#PrimeMedicine - exclusive rights for #PrimeEditing for transition mutations
6/@BeamTx is also, as of today, the #CRISPR company with the most extensive & vast collaboration agreements portfolio: 1)@VerveTx - cardiovascular disease 2) $SANA - non-exclusive license for #Cas12 3)#PrimeMedicine - exclusive rights for #PrimeEditing for transition mutations
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.1M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.2M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
88.8M followers
Taylor Swift
@taylorswift13
82.7M followers
Lady Gaga
@ladygaga
74.2M followers
Virat Kohli
@imvkohli
71.6M followers
Kim Kardashian
@kimkardashian
70.3M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
64.5M followers
Bill Gates
@billgates
64.5M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
61.9M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers